Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 12-Sep-24
Select bar for recommendation details.
Recommendations | 12-Sep-24 | |
---|---|---|
Buy | 0 | |
Outperform | 2 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 2 analysts offering 12 month price targets for Neurosense Therapeutics Ltd have a median target of 5.25, with a high estimate of 7.50 and a low estimate of 3.00. The median estimate represents a 288.89% increase from the last price of 1.35.
High | 455.6% | 7.50 |
Med | 288.9% | 5.25 |
Low | 122.2% | 3.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Sep 20, 2024.
Average growth rate | -118.75% |
More ▼